ACTAVIS RECEIVES WARNING FROM FDA

Icelandic generic pharmaceuticals company Actavis said that it has received a warning letter from the FDA relating to the company's solid oral dose manufacturing facility in New Jersey, US. Pharmaceutical Business Review (http://www.pharmaceutical-business-review.com/article_news.asp?guid=AEE1D6E6-EB09-4925-9F7B-080B8F31EAC2)